Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Oct 31, 2025 | (Q2)Jul 31, 2025 | (Q1)Apr 30, 2025 | (FY)Jan 31, 2025 | (Q4)Jan 31, 2025 | (Q3)Oct 31, 2024 | (Q2)Jul 31, 2024 | (Q1)Apr 30, 2024 | (FY)Jan 31, 2024 | (Q4)Jan 31, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.99%20.86M | -17.38%18.25M | -11.05%20.21M | -16.08%84.87M | -25.05%19.6M | -20.69%20.45M | -15.96%22.09M | -0.80%22.72M | -15.99%101.13M | -3.97%26.15M |
| Cost of revenue | -24.48%68.14M | -3.32%90.22M | ||||||||
| Gross profit | 53.33%16.73M | -59.69%10.91M | ||||||||
| Operating expense | 3.63%20.24M | -8.33%18.81M | -7.68%20M | -8.83%11.71M | -29.80%18.39M | -22.88%19.53M | -22.72%20.52M | -13.37%21.67M | -10.62%12.84M | 138.72%26.2M |
| Staff costs | ---- | ---- | ---- | -17.83%4.02M | ---- | ---- | ---- | ---- | -15.80%4.89M | ---- |
| Selling and administrative expenses | ---- | ---- | ---- | -3.61%7.04M | ---- | ---- | ---- | ---- | -9.05%7.31M | ---- |
| -Selling and marketing expense | ---- | ---- | ---- | 0.26%1.95M | ---- | ---- | ---- | ---- | -45.65%1.95M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -5.02%5.09M | ---- | ---- | ---- | ---- | 20.44%5.36M | ---- |
| Depreciation and amortization | ---- | ---- | ---- | -0.16%617K | ---- | ---- | ---- | ---- | 22.13%618K | ---- |
| -Depreciation | ---- | ---- | ---- | -0.16%617K | ---- | ---- | ---- | ---- | 22.13%618K | ---- |
| Rent and land expenses | ---- | ---- | ---- | 6.06%35K | ---- | ---- | ---- | ---- | 22.22%33K | ---- |
| Other operating expenses | 3.63%20.24M | -8.33%18.81M | -7.68%20M | -22.29%80.12M | -29.80%18.39M | -22.88%19.53M | -22.72%20.52M | -13.37%21.67M | --103.1M | --26.2M |
| Operating profit | -32.93%617K | -135.30%-556K | -80.32%207K | 359.65%5.02M | 2,208.77%1.2M | 100.00%920K | 705.77%1.58M | 149.93%1.05M | -115.23%-1.93M | -103.60%-57K |
| Net non-operating interest income (expenses) | 49.60%-314K | 24.15%-380K | 9.07%-421K | 7.79%-1.41M | 12.81%-456K | -25.10%-623K | 10.54%-501K | 13.46%-463K | 18.77%-1.53M | -1.55%-523K |
| Non-operating interest income | ---- | ---- | ---- | 7.82%634K | ---- | ---- | ---- | ---- | 600.00%588K | ---- |
| Non-operating interest expense | -49.60%314K | -24.15%380K | -9.07%421K | -3.45%2.04M | -12.81%456K | 25.10%623K | -10.54%501K | -13.46%463K | 7.68%2.12M | -12.69%523K |
| Net investment income | -101.60%-255K | 4,314.96%15.94M | ||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | 1K | 0 | ||||||||
| Income from associates and other participating interests | ||||||||||
| Special income (charges) | -41.18%-24K | -125.00%-2K | 13.79%-50K | -852.83%-798K | -716K | -119.32%-17K | 8K | -627.27%-58K | 137.99%106K | 0 |
| Less:Impairment of capital assets | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- |
| Less:Other special charges | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 52.38%-20K | ---- |
| Less:Write off | 41.18%24K | 125.00%2K | -13.79%50K | 1,027.91%798K | --716K | 119.32%17K | ---8K | 627.27%58K | -127.48%-86K | --0 |
| Other non-operating income (expenses) | -10.51%264K | 22.30%329K | 7.23%267K | -37.01%451K | -72.20%273K | -22.77%295K | -35.95%269K | -98.39%249K | -53.93%716K | 379.77%982K |
| Income before tax | -5.57%543K | -145.08%-609K | -99.62%3K | -77.37%3.01M | -24.63%303K | 33.10%575K | 437.75%1.35M | -93.93%780K | 6.83%13.3M | -49.81%402K |
| Income tax | -44.70%146K | -56.76%112K | -10.77%174K | 340.16%1.1M | 124.87%378K | 203.45%264K | 208.33%259K | -87.72%195K | -92.93%249K | -241.00%-1.52M |
| Net income | 27.65%397K | -166.03%-721K | -129.23%-171K | -85.34%1.91M | -103.90%-75K | -9.86%311K | 325.62%1.09M | -94.81%585K | 46.19%13.05M | 793.86%1.92M |
| Net income continuous operations | 27.65%397K | -166.03%-721K | -129.23%-171K | -85.34%1.91M | -103.90%-75K | -9.86%311K | 325.62%1.09M | -94.81%585K | 46.19%13.05M | 793.86%1.92M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 27.65%397K | -166.03%-721K | -129.23%-171K | -85.34%1.91M | -103.90%-75K | -9.86%311K | 325.62%1.09M | -94.81%585K | 46.19%13.05M | 793.86%1.92M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 27.65%397K | -166.03%-721K | -129.23%-171K | -85.34%1.91M | -103.90%-75K | -9.86%311K | 325.62%1.09M | -94.81%585K | 46.19%13.05M | 793.86%1.92M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 30.00%0.0026 | -165.28%-0.0047 | -128.95%-0.0011 | -85.41%0.0125 | -103.97%-0.0005 | -13.04%0.002 | 325.00%0.0072 | -94.88%0.0038 | 45.01%0.0857 | 730.00%0.0126 |
| Diluted earnings per share | 30.00%0.0026 | -165.28%-0.0047 | -128.95%-0.0011 | -85.40%0.0125 | -103.97%-0.0005 | -13.04%0.002 | 325.00%0.0072 | -94.88%0.0038 | 44.84%0.0856 | 730.00%0.0126 |
| Dividend per share | ||||||||||
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.